市場調查報告書

基因學市場:成長,趨勢,預測(2020∼2025)

Genomics Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 925560
出版日期 內容資訊 英文 120 Pages
商品交期: 2-3個工作天內
價格
基因學市場:成長,趨勢,預測(2020∼2025) Genomics Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年02月01日內容資訊: 英文 120 Pages
簡介

基因學市場在預測期間內預計將以9.3%的年複合成長率成長。基因學市場主要成長要素,是政府的輔助增加和基因學研究數的增加,序列成本低,基因學的用途增加。基因學市場上指數函數的成長,是由於根本的遺傳基因開發的結果。還有上位性,雜交優勢,多效性,及對偶基因和基因座之間的基因內其他關連等很多的研究領域的用途也成為成長要素。並且,將基因學市場推向新高度上發揮重要作用的也有他幾個要素。其中,在生物工程和合成生物學中的用途有望促進基因組學市場的發展。

本報告提供基因學市場調查,市場概要,各市場成長要素及阻礙因素分析,產品,各類服務、各技術、各要點、各終端用戶、各地區的市場規模的變化與預測,競爭情形,主要企業的簡介,市場機會等全面性資訊。

目錄

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 市場概要
  • 市場成長要素
    • 基因學的應用領域的擴大和政府資金的增加
    • 序列成本低
  • 市場阻礙因素
    • 設備費高
  • 波特的五力分析

第5章 市場細分化

  • 各產品及服務
    • 消耗品
    • 系統和軟體
    • 服務
  • 各技術
    • PCR
    • 序列
    • 微陣列
    • 核酸的萃取與精製
    • 其他
  • 各用途
    • 診斷
    • 藥物研發與開發
    • 精密醫學
    • 其他
  • 各終端用戶
    • 醫院和診所
    • 研究中心
    • 製藥及生物科技企業
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲地區
    • 南美

第6章 競爭情形

  • 企業簡介
    • Illumina, Inc.
    • Thermo Fisher Scientific
    • Agilent Technologies
    • Luminex Corporation
    • Myriad Genetics, Inc.
    • Perkinelmer Inc.
    • GE Healthcare
    • F. Hoffmann-La Roche Ltd.
    • Pacific Biosciences of California, Inc.
    • QIAGEN

第7章 市場機會及未來趨勢

目錄
Product Code: 67971

The Genomics market studied was anticipated to grow with a CAGR of 9.3%, during the forecast period. The major factors attributing to the growth of the genomics market are growing government support and increased number of genomics studies, declining sequencing cost, increased genomics applications. The genomics market is geared to exponential growth as a result of the essential genetic developments and also because of its applications in numerous areas of study, such as intragenomic phenomena like epistasis, heterosis, pleiotropy, and other associations within the genome between alleles and loci. And there are few more factors which are playing crucial roles in taking the genomics market to the next level, among them one is on-bioengineering and synthetic biology applications which are expected to further propel the growth of the genomics market.

Key Market Trends

Consumables Segment is Expected to Hold the Largest Market Share in the Genomics Market

  • Genomics is widely used in medical, biotechnology, agriculture, diagnostics, and DNA Sequencing. Genomics is used in the healthcare sector to build vaccines and medicines. The use of consumables while making vaccines and drugs and in their testing have great applications.
  • According to the U.S. National Center for Biotechnology Data, oncology expenditure (research and treatment of tumors) is projected to increase by 7 percent - 10 percent yearly through 2020, with universal oncology costs approaching $150 billion. The use of genomics in making possible biomarkers for cancers and in the exploration of cell-free circulating DNA by several R&D sectors is upsurging the market growth.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall genomics market, throughout the forecast period. This is owing to the factors such as the rising incidence of chronic diseases such as cancer, increasing government entities investment in research, raising awareness of patients, and the availability of advanced healthcare infrastructure has contributed to growing technological advances in this sector and rising demand for biotechnological practices in the region, is anticipated to further drive the growth in this region. Further, the domicile presence of some of the major players in the region is also ensuring the dominance of the region.

Competitive Landscape

The genomics market is moderately competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. And some prominent players are vigorously making acquisitions and joint ventures with the other companies to consolidate their market positions across the globe. Some of the companies which are currently dominating the market are Illumina, Inc., Thermo Fisher Scientific, Agilent Technologies, Luminex Corporation, and Myriad Genetics, Inc.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Application area of Genomics and Increasing Government Funding
    • 4.2.2 Declining Sequencing Cost
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Equipment
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product & Services
    • 5.1.1 Consumables
    • 5.1.2 Systems & Software
    • 5.1.3 Services
  • 5.2 By Techniques
    • 5.2.1 PCR
    • 5.2.2 Sequencing
    • 5.2.3 Microarray
    • 5.2.4 Nucleic Acid Extraction and Purification
    • 5.2.5 Others
  • 5.3 By Application
    • 5.3.1 Diagnostics
    • 5.3.2 Drug Discovery and Development
    • 5.3.3 Precision Medicine
    • 5.3.4 Others
  • 5.4 By End User
    • 5.4.1 Hospitals & Clinics
    • 5.4.2 Research Centers
    • 5.4.3 Pharmaceutical and Biotechnology Companies
    • 5.4.4 Others
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 United Kingdom
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle-East and Africa
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle-East and Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Illumina, Inc.
    • 6.1.2 Thermo Fisher Scientific
    • 6.1.3 Agilent Technologies
    • 6.1.4 Luminex Corporation
    • 6.1.5 Myriad Genetics, Inc.
    • 6.1.6 Perkinelmer Inc.
    • 6.1.7 GE Healthcare
    • 6.1.8 F. Hoffmann-La Roche Ltd.
    • 6.1.9 Pacific Biosciences of California, Inc.
    • 6.1.10 QIAGEN

7 MARKET OPPORTUNITIES AND FUTURE TRENDS